NV Tablet is a combination pharmaceutical formulation containing Doxylamine 10 mg, Vitamin B6 (Pyridoxine) 10 mg, and Folic Acid 2.5 mg, indicated primarily for the management of nausea and vomiting, particularly in pregnancy. Doxylamine, an antihistamine with sedative properties, acts by antagonizing central histamine H1 receptors, thereby reducing the sensation of nausea and preventing vomiting. Vitamin B6 plays a crucial role in neurotransmitter synthesis and is widely recognized for its efficacy in alleviating nausea symptoms. Folic Acid, a vital B-vitamin, is essential for DNA synthesis and cellular growth, and its inclusion supports fetal neural tube development, reducing the risk of congenital anomalies during pregnancy. NV Tablet is typically prescribed to pregnant women experiencing morning sickness, providing symptomatic relief while contributing to prenatal nutritional requirements. The combination ensures a synergistic effect, improving patient compliance by reducing the pill burden. It is advised to use NV Tablet under medical supervision, especially in patients with hypersensitivity to any components, or those with pre-existing medical conditions. Common adverse effects may include drowsiness, dry mouth, or gastrointestinal discomfort. NV Tablet should be administered as per the prescribed dosage to maximize therapeutic benefits while minimizing potential risks.